Jolessa
Product Images NDC 53002-1779

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Jolessa (NDC 53002-1779). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

00555912366part1of2

Jolessa round, pink tablet imprinted with 'F 6' on one side and '9792' on the other side, shown against a gray background with a millimeter scale. The image focuses on the tablet's size and imprint details.*

FDA Label Image

00555912366part2of2

Round, white tablet imprinted with a lowercase 'b' on one side and the number '208' on the other side. The pill is shown with a millimeter scale for size reference. This tablet image is associated with Jolessa, a product labeled by RPK Pharmaceuticals, Inc.*

FDA Label Image

Figure A (Jolessa Levonorgestrel Ethinyl Estradiol Kit 1)

Jolessa oral contraceptive blister pack showing two 91-pill cards. Each card contains 7 rows and 7 columns of circular tablets labeled by day of the week from Sunday to Saturday. The pack states the active ingredients levonorgestrel and ethinyl estradiol with strengths of 0.15 mg and 0.03 mg respectively. The labeler is RPK Pharmaceuticals, Inc.*

FDA Label Image

Figure B (Jolessa Levonorgestrel Ethinyl Estradiol Kit 2)

Blister card packaging label for Jolessa (levonorgestrel/ethinyl estradiol tablets) 0.15 mg/0.03 mg. The card displays 28 circular tablet compartments arranged in four rows, labeled for days of the week from Sunday to Saturday. It includes prescription use designation and package quantity of 91 tablets. The labeler is RPK Pharmaceuticals, Inc.*

FDA Label Image

Levonorgestrel (Jolessa Levonorgestrel Ethinyl Estradiol Kit 3)

Chemical structure diagram of an active ingredient associated with Jolessa, showing a steroid-like four-ring core with functional groups including a hydroxyl (OH), methyl (CH3), and an alkyne group (triple bond with CH).*

FDA Label Image

Ethinyl Estradiol (Jolessa Levonorgestrel Ethinyl Estradiol Kit 4)

Chemical structure of the active ingredient in Jolessa, as shown in the provided image. The structure features a complex steroidal framework with multiple hydroxyl groups and double bonds, typical of hormonal compounds.*

FDA Label Image

Chart (Jolessa Levonorgestrel Ethinyl Estradiol Kit 5)

An effectiveness chart ranking various birth control methods by likelihood of pregnancy per 100 women per year. Methods with fewer pregnancies include implants, injections, intrauterine devices, and sterilization. Birth control pills, skin patch, and vaginal ring with hormones follow. Condoms and diaphragm have moderate pregnancy rates. Least effective methods listed are fertility awareness, spermicide, and withdrawal, with no birth control resulting in the highest pregnancy rate.*

FDA Label Image

Figure A (Jolessa Levonorgestrel Ethinyl Estradiol Kit 6)

Two Jolessa tablet blister cards, each showing a 91-day regimen layout for 91 tablets. Each card is labeled with the brand name Jolessa, containing levonorgestrel and ethinyl estradiol 0.15 mg/0.03 mg tablets. The blister card design includes day-of-week markings and instructions to see lot and expiration information on the reverse side. The labeler is RPK Pharmaceuticals, Inc.*

FDA Label Image

Figure B (Jolessa Levonorgestrel Ethinyl Estradiol Kit 7)

Jolessa oral contraceptive tablet pack containing 91 tablets in a calendar-style blister pack. Each tablet includes 0.15 mg levonorgestrel and 0.03 mg ethinyl estradiol, organized by days of the week from Sunday to Saturday. The pack shows 28 tablets per cycle with 21 active and 7 inactive tablets. Labeler is RPK Pharmaceuticals, Inc.*

FDA Label Image

Figure C (Jolessa Levonorgestrel Ethinyl Estradiol Kit 8)

Jolessa (levonorgestrel/ethinyl estradiol) tablets blister pack contains 91 oral contraceptive tablets. The label shows a 13-week regimen with days of the week in columns and a hand pointing to Sunday. Each tablet is 0.15 mg levonorgestrel and 0.03 mg ethinyl estradiol. The blister pack is labeled by RPK Pharmaceuticals, Inc.*

FDA Label Image

Label Image (Lbl530021779)

Jolessa 0.15/0.03 mg tablets carton label showing a 91-tablet pack. The label states to take one tablet daily as directed. It includes the labeler name, RPK Pharmaceuticals, Inc., and various regulatory details and lot numbers. Space is indicated for clinic name and prescription information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.